The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies. 

Market Growth Overview

• Current Market Size: The calcium gluconate market reached $101.97 billion in 2023.
• Annual Growth: It is projected to grow to $110.12 billion by 2024, reflecting an 8% compound annual growth rate (CAGR).
• Historical Growth Drivers:
  • Economic growth and industrialization
  • Increased use in functional foods
  • Rising demand for pharmaceuticals and dietary supplements
  • Growing awareness of calcium deficiency
  • Supportive regulatory environment for food additives

Future Projections

• Long-Term Growth: The market is expected to reach $150.62 billion by 2028, with a CAGR of 8.1%.
• Key Growth Drivers:
  • Aging population and increased health awareness
  • Expansion in the food and beverage industry
  • Growth in digital marketing and e-commerce
  • Shift toward natural and organic products
  • Urbanization and emerging markets

View More On The Calcium Gluconate Market Report 2024 – https://www.thebusinessresearchcompany.com/report/calcium-gluconate-global-market-report

Trends Shaping the Market

• Healthcare R&D: Focus on sustainable sourcing and production
• Medical Integration: Increased use in medical treatments
• Customized Formulations: Tailored for specific health needs
• Technological Advancements: Innovations in manufacturing processes

Impact of Osteoporosis on Market Growth

• Rising Incidence: Osteoporosis contributes significantly to health issues, driven by sedentary lifestyles and inadequate calcium intake.
• Market Influence:
  • Calcium gluconate helps in managing osteoporosis by supplementing dietary calcium.
  • In Australia (2023), osteoporosis led to 2,366 deaths and 9,500 hospitalizations, highlighting its impact on healthcare.
  • This growing incidence fuels demand for calcium gluconate.

Key Players and Innovations

• Major Companies:
  • Merck & Co. Inc.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Novartis AG
  • Eli Lilly and Company
  • And many others
• Recent Developments:
  • Amneal Pharmaceuticals Inc.: Received FDA approval for a calcium gluconate injection in September 2023, enhancing treatment options for acute symptomatic hypocalcemia.

Strategic Acquisitions

• Azelis Group: Acquired Spectrum Chemicals and Nortons Exim in April 2021, expanding its footprint in India and access to emerging markets. Spectrum Chemicals supplies calcium gluconate anhydrous powder.

Market Segmentation

• By Form: Liquid, Tablet, Powder, Gel
• By Grade: Pharmaceutical Grade, Food Grade
• By Application:
  • Food and Beverage Manufacturers
  • Pharmaceutical
  • Nutraceutical
  • Cosmetic and Personal Care
  • Other Applications
• By End Use:
  • Emulsifier
  • Bulking Agent
  • Thickening Agent

Regional Insights

• Leading Region: Europe was the largest market in 2023.
• Fastest Growing: Asia-Pacific is expected to experience the most rapid growth during the forecast period.

The calcium gluconate market is poised for robust growth driven by increasing health consciousness, innovative product developments, and a focus on addressing calcium deficiencies.

Request A Sample Of The Global Calcium Gluconate Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16005&type=smp